Blog
About

27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The FGF family: biology, pathophysiology and therapy.

      Nature reviews. Drug discovery

      Animals, therapeutic use, antagonists & inhibitors, Metabolic Syndrome X, metabolism, Humans, Homeostasis, Receptors, Fibroblast Growth Factor, Neoplasms, physiology, Hypophosphatemia, Cardiovascular Diseases, drug therapy, physiopathology, Fibroblast Growth Factors

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The family of fibroblast growth factors (FGFs) regulates a plethora of developmental processes, including brain patterning, branching morphogenesis and limb development. Several mitogenic, cytoprotective and angiogenic therapeutic applications of FGFs are already being explored, and the recent discovery of the crucial roles of the endocrine-acting FGF19 subfamily in bile acid, glucose and phosphate homeostasis has sparked renewed interest in the pharmacological potential of this family. This Review discusses traditional applications of recombinant FGFs and small-molecule FGF receptor kinase inhibitors in the treatment of cancer and cardiovascular disease and their emerging potential in the treatment of metabolic syndrome and hypophosphataemic diseases.

          Related collections

          Author and article information

          Journal
          19247306
          3684054
          10.1038/nrd2792

          Comments

          Comment on this article